Prevtec microbia’s Board of Directors sets the company’s broad strategic objectives and allocates financial resources to ensure its growth. The Board comprises the company’s senior executives plus independent directors appointed by the investors.

" Bertrand F. Bolduc, BPharm., MBA
Chairman of Galenova "

" John M. Fairbrother, BVSc, PhD
Professor at Université de Montréal and Director of the EcL Laboratory "

" Michel Fortin, CA, CMA
President and CEO of Prevtec microbia "

" Douglas Kern, DVM, MS
Vice President, Business Development, of VGX Animal Health "

" Éric Nadeau, DMV, PhD
Vice-President of Scientific Affairs, Prevtec microbia "

" Jean-Paul Tardif, BScA, MBA, CBV
Associate Director of ID Capital Management "

" Jean-Simon Venne, BEng
President of NIRIC "

Scientific Committee

Prevtec microbia has a Scientific Committee, composed of experts from various fields relevant to the company’s business.

The main role of the Committee is to advise on the company’s research and development goals, and on its scientific policy.

" John M. Fairbrother, BVSc, PhD, Chairman of the Committee
Professor at Université de Montréal and Director of the EcL Laboratory
Veterinarian microbiologist, researcher of international renown "

" Stan Alkemade, BVSc
President of BioMedEx
International consultant on regulatory matters to the biopharmaceutical industry "

" Michel Fortin, CA, CMA
President and CEO of Prevtec microbia "

" Robert Gauthier, DMV
Director of Research and Development, Jefo
Veterinarian with extensive experience in pig production, poultry and animal feed "

" Éric Nadeau, DMV, PhD
Vice-President of Scientific Affairs, Prevtec microbia "

" Louis Provencher, PhD, DA
Business Development Manager, Life Sciences, Univalor
Expertise in organic and medical chemistry, enzymology, biology and endocrinology "

" Jean-Paul Tardif, BScA, MBA, CBV, observer on the Committee
Associate Director of ID Capital Management "